MarketInOut Stock Screener Log In | Sign Up

Parnax Lab Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:56
Parnax Lab Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization1,185.89 mln
Float2.85 mln

EPS

7.79
Strong

P / E

13.25
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.05
Caution advised

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.87
Moderate leverage

Business Description

Parnax Lab Limited is an India-based pharmaceutical company founded in 1982 and headquartered in Mumbai, producing and exporting a wide range of medicines, health supplements, herbal products, and cosmetics. Its product lineup covers everything from cough syrups and antacids to vitamins, creams, tablets, and capsules, serving both domestic and international markets. The company also helps other businesses by offering drug development, licensing support, and contract manufacturing services.

Key Fundamentals

EPS7.79
P/E13.25
ROE10.01
RPS220
ROIC6.25
ROA4.29
Interest Cover2.58
EBITDA, mln265
EV / EBITDA7.53
EV / EBIT10.98
Revenue, mln2,520
EV / Revenue0.79

Quote Details

Last 103.25
Change -0.47 (-0.45%)
Open 105.79
Volume 3,227
Turnover 333,188
Average Volume 3,201.71

Financial Ratios

Pre-Tax Profit Margin5
Current Ratio0.95
Price / Book1.31
Price / Tangible Book1.32
Debt / Equity0.87
Price / Sales0.49
PEG Ratio1.29

Financial Strength

Altman Z-Score2.3
Piotroski F-Score 6 / 9
Beneish M-Score-2.05
Price to Lynch Fair Value1.94
Price to Graham Number0.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.66% 58 / 100   
1 Month -12.66% 26 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog